{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T06:14:53Z","timestamp":1790316893164,"version":"4.1.0"},"reference-count":45,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.ijrobp.2008.04.020","type":"journal-article","created":{"date-parts":[[2008,7,19]],"date-time":"2008-07-19T08:45:39Z","timestamp":1216457139000},"page":"1477-1484","source":"Crossref","is-referenced-by-count":22,"title":["Antiangiogenic Effects of Noscapine Enhance Radioresponse for GL261 Tumors"],"prefix":"10.1016","volume":"71","author":[{"given":"Elizabeth W.","family":"Newcomb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yevgeniy","family":"Lukyanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Alonso-Basanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mine","family":"Esencay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iva","family":"Smirnova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tona","family":"Schnee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongzhao","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Louise","family":"Devitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Zagzag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"McBride","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia C.","family":"Formenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2008.04.020_bib1","first-page":"2807","article-title":"Prolonged tumor dormancy by prevention of neovascularization in the vitreous","volume":"36","author":"Brem","year":"1976","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib2","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","article-title":"Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer","volume":"350","author":"Hurwitz","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1634\/theoncologist.11-2-152","article-title":"Therapeutic advances in the treatment of glioblastoma: Rationale and potential role of targeted agents","volume":"11","author":"Reardon","year":"2006","journal-title":"Oncologist"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/roi.2970020604","article-title":"Antiangiogenic agents can increase tumor oxygenation and response to radiation therapy","volume":"2","author":"Teicher","year":"1995","journal-title":"Radiat Oncol Invest"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib5","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/BF00437479","article-title":"A systems approach to cancer therapy. (Antioncogenics + standard cytotoxics \u2192 mechanism(s) of interaction)","volume":"15","author":"Teicher","year":"1996","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib6","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/28412","article-title":"Combined effect of angiostatin and ionizing radiation in antitumour therapy","volume":"394","author":"Mauceri","year":"1998","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib7","article-title":"Blockade of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation","volume":"59","author":"Gorski","year":"1999","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib8","first-page":"5565","article-title":"Anti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditions","volume":"60","author":"Lee","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib9","first-page":"2413","article-title":"Inhibition of vascular endothelial growth factor receptor signaling leads to reversal of tumor resistance to radiotherapy","volume":"61","author":"Geng","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib10","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.1054\/bjoc.2001.2166","article-title":"Effect of VEGF receptor inhibitor PTK787\/ZK222584 combined with ionizing radiation on endothelial cells and tumour growth","volume":"85","author":"Hess","year":"2001","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib11","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.ijrobp.2003.10.049","article-title":"Broad spectrum receptor tyrosine kinase inhibitor, SU6668, sensitizes radiation via targeting survival pathway of vascular endothelium","volume":"58","author":"Lu","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.ijrobp.2004.09.063","article-title":"Radiation combined with SU5416: Microvascular changes and growth delay in a human xenograft glioblastoma tumor line","volume":"61","author":"Schuuring","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib13","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.ijrobp.2006.10.030","article-title":"Endostatin improves radioresponse and blocks tumor revascularization after radiation therapy for A431 xenografts in mice","volume":"67","author":"Itasaka","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib14","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1016\/j.ijrobp.2006.11.011","article-title":"VEGF trap in combination with radiotherapy improves tumor control in U87 glioblastoma","volume":"67","author":"Wachsberger","year":"2007","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib15","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ijrobp.2005.02.008","article-title":"Molecular strategies targeting the host component of cancer to enhance tumor response to radiation therapy","volume":"64","author":"Kim","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib16","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ctrv.2006.03.006","article-title":"Current status of angiogenesis inhibitors combined with radiation therapy","volume":"32","author":"Nider","year":"2006","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/277665a0","article-title":"Promotion of microtubule assembly in vitro by Taxol","volume":"277","author":"Schiff","year":"1979","journal-title":"Nature"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib18","first-page":"1843","article-title":"The microtubule-affecting drug paclitaxel has antiangiogenic activity","volume":"2","author":"Belotti","year":"1996","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/ijc.10907","article-title":"Comparison of antiangiogenic activities using paclitaxel (Taxol) and docetaxel (Taxotere)","volume":"104","author":"Grant","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib20","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1097\/01.COC.0000072504.22544.3C","article-title":"Targeting angiogenic processes by combination low-dose paclitaxel and radiation therapy","volume":"26","author":"Dicker","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib21","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1073\/pnas.95.4.1601","article-title":"Opium alkaloid noscapine is an antitumor agent that arrests metaphase and induces apoptosis in dividing cells","volume":"95","author":"Ye","year":"1998","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib22","doi-asserted-by":"crossref","first-page":"3782","DOI":"10.1158\/0008-5472.CAN-05-2962","article-title":"Rational design of the microtubule-targeting anti-breast cancer drug EM015","volume":"66","author":"Aneja","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib23","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.patbio.2005.03.003","article-title":"Update on tubulin-binding agents","volume":"54","author":"Attard","year":"2006","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib24","first-page":"1121","article-title":"Noscapine inhibits hypoxia-mediated HIF-1\u03b1 expression and angiogenesis in vitro: a novel function for an old drug","volume":"28","author":"Newcomb","year":"2006","journal-title":"Int J Oncol"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib25","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2407-5-76","article-title":"The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism","volume":"5","author":"Pajonk","year":"2005","journal-title":"BMC Cancer"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib26","first-page":"3564","article-title":"Role of reoxygenation in induction of enhancement of tumor radioresponse by paclitaxel","volume":"55","author":"Milas","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib27","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0959-8049(97)00107-X","article-title":"Enhanced radioresponse of paclitaxel-sensitive and -resistant tumor in vivo","volume":"33","author":"Milross","year":"1997","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib28","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.surneu.2005.06.024","article-title":"Noscapine and diltiazem augment Taxol and radiation-induced S-phase arrest and clonogenic death of C6 glioma in vitro","volume":"65","author":"Altinoz","year":"2006","journal-title":"Surg Neurol"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib29","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1158\/1078-0432.CCR-03-1013","article-title":"Murine endothelial cell lines as models of tumor endothelial cells","volume":"10","author":"Walter-Yohrling","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib30","doi-asserted-by":"crossref","first-page":"11409","DOI":"10.1158\/0008-5472.CAN-06-2414","article-title":"Vascular endothelial growth factor tyrosine kinase inhibitor AZD2171 and fractionated radiotherapy in mouse models of lung cancer","volume":"66","author":"Cao","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib31","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/nm0901-987","article-title":"Normalizing tumor vasculature with anti-angiogenic therapy: A new paradigm for combination therapy","volume":"7","author":"Jain","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib32","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.mvr.2007.05.003","article-title":"Tumor microvasculature and microenvironment: Targets for anti-angiogenesis and normalization","volume":"74","author":"Fukumura","year":"2007","journal-title":"Microvasc Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib33","first-page":"1957","article-title":"Tumor response to ionizing radiation combined with antiangiogenesis or vascular targeting agents: Exploring mechanisms of interaction","volume":"9","author":"Wachsberger","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ccr.2005.07.014","article-title":"Engaging the vascular component of the tumor response","volume":"8","author":"Fuks","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib35","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s002800050466","article-title":"Comparison of several antiangiogenic regimens alone and with cytotoxic therapies in the Lewis lung carcinoma","volume":"38","author":"Teicher","year":"1996","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib36","first-page":"971","article-title":"Therapeutic synergy of TNP-470 and ionizing radiation: Effects on tumor growth, vessel morphology, and angiogenesis in human glioblastoma multiforme xenografts","volume":"6","author":"Lund","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib37","first-page":"6958","article-title":"NM-3, an isocoumarin, increases the antitumor effects of radiotherapy without toxicity","volume":"60","author":"Salloum","year":"2000","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib38","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1158\/0008-5472.CAN-05-2209","article-title":"Alpha-sulfoquinovosylmonoacylglycerol is a novel potent radiosensitizer targeting tumor angiogenesis","volume":"66","author":"Sakimoto","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib39","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s10147-006-0625-y","article-title":"Antiangiogenesis therapy using a novel angiogenesis inhibitor, anginex, following radiation cause tumor growth delay","volume":"12","author":"Amano","year":"2007","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib40","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1158\/1078-0432.CCR-06-2441","article-title":"Scheduling of radiation with angiogenesis inhibitors Anginex and Avastin improves therapeutic outcome via vessel normalization","volume":"13","author":"Dings","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib41","first-page":"553","article-title":"Kinetics of vascular normalization by VEGFR2 blockade governs brain tumor response to radiation: Role of oxygenation, angiopoietin-1, and matrix metalloproteinases","volume":"6","author":"Winkler","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1158\/1078-0432.743.11.2","article-title":"Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment","volume":"11","author":"Ansiaux","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1750-3639.2005.tb00115.x","article-title":"Angiogenesis in gliomas: Biology and molecular pathophysiology","volume":"15","author":"Fischer","year":"2005","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib44","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1750-3639.2005.tb00119.x","article-title":"Angiogenesis in gliomas: Imaging and experimental therapeutics","volume":"15","author":"Gagner","year":"2005","journal-title":"Brain Pathol"},{"key":"10.1016\/j.ijrobp.2008.04.020_bib45","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1038\/labinvest.3780088","article-title":"Vascular apoptosis and evolution in gliomas precede neovascularization: A novel concept for glioma growth and angiogenesis","volume":"80","author":"Zagzag","year":"2000","journal-title":"Lab Invest"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301608006767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0360301608006767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T07:28:36Z","timestamp":1684481316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0360301608006767"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":45,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2008,8]]}},"alternative-id":["S0360301608006767"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2008.04.020","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}